Cargando…

ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease, which warrants the critical need to identify new therapeutic targets. We show that Zinc Fingers and Homeoboxes 2 (ZHX2) is amplified or overexpressed in TNBC cell lines and patients. Functionally, depletion of ZHX2 inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Wentong, Liao, Chengheng, Shi, Rachel, Simon, Jeremy M, Ptacek, Travis S, Zurlo, Giada, Ye, Youqiong, Han, Leng, Fan, Cheng, Bao, Lei, Ortiz, Christopher Llynard, Lin, Hong-Rui, Manocha, Ujjawal, Luo, Weibo, Peng, Yan, Kim, William Y, Yang, Lee-Wei, Zhang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2021
Materias:	Cancer Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8673836/ https://www.ncbi.nlm.nih.gov/pubmed/34779768 http://dx.doi.org/10.7554/eLife.70412

Ejemplares similares

USP13 promotes deubiquitination of ZHX2 and tumorigenesis in kidney cancer
por: Xie, Haibiao, et al.
Publicado: (2022)

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
por: Jiang, Jifeng, et al.
Publicado: (2020)

ZHX2 in health and disease
por: Li, Na, et al.
Publicado: (2022)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Zurlo, Giada, et al.
Publicado: (2019)

Optimized protocols for chromatin immunoprecipitation of exogenously expressed epitope-tagged proteins
por: Fang, Wentong, et al.
Publicado: (2023)

ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells
por: Kwon, Ryuk-Jun, et al.
Publicado: (2016)

Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
por: Cai, Zhai, et al.
Publicado: (2023)

Antitumor pharmacotherapy of colorectal cancer in kidney transplant recipients
por: Fu, Yuanyuan, et al.
Publicado: (2019)

The testis protein ZNF165 is a SMAD3 cofactor that coordinates oncogenic TGFβ signaling in triple-negative breast cancer
por: Gibbs, Zane A, et al.
Publicado: (2020)

MT1X is an oncogene and indicates prognosis in ccRCC
por: Ding, Yanpeng, et al.
Publicado: (2022)

ZHX2 is a repressor of α-fetoprotein expression in human hepatoma cell lines
por: Shen, H, et al.
Publicado: (2008)

Transcription factor Zhx2 restricts NK cell maturation and suppresses their antitumor immunity
por: Tan, Siyu, et al.
Publicado: (2021)

Upregulation of ZHX2 predicts poor prognosis and is correlated with immune infiltration in gastric cancer
por: Cheng, Anqi, et al.
Publicado: (2021)

Claspin haploinsufficiency leads to defects in fertility, hyperplasia and an increased oncogenic potential
por: Madgwick, Suzanne, et al.
Publicado: (2022)

Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
por: Keremu, Ajimu, et al.
Publicado: (2019)

ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14
por: Zhang, Yankun, et al.
Publicado: (2022)

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy
por: You, Yanjie, et al.
Publicado: (2022)

Zhx2 maintains islet β-cell mass and function by transcriptionally regulating Pax6
por: Ding, Lu, et al.
Publicado: (2023)

ZHX2 deficiency enriches hybrid MET cells through regulating E-cadherin expression
por: He, Yan, et al.
Publicado: (2023)

β-glucan from Lentinus edodes inhibits breast cancer progression via the Nur77/HIF-1α axis
por: Zhang, Xiuru, et al.
Publicado: (2020)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

When oncogenes do not cause cancer
por: Shiu, Jessica, et al.
Publicado: (2021)

ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Ma, Xingjie, et al.
Publicado: (2016)

Loss of the transcription repressor ZHX3 induces senescence-associated gene expression and mitochondrial-nucleolar activation
por: Igata, Tomoka, et al.
Publicado: (2022)

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury
por: Zhang, Yankun, et al.
Publicado: (2023)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Blocking lncRNA MALAT1/miR-199a/ZHX1 Axis Inhibits Glioblastoma Proliferation and Progression
por: Liao, Keman, et al.
Publicado: (2019)

Mechanisms of Oncogenic Cooperation in Cancer Initiation and Metastasis
por: Pedraza-Fariña, Laura G.
Publicado: (2007)

Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
por: Urtatiz, Oscar, et al.
Publicado: (2021)

Enhancer Coamplification and Hijacking Promote Oncogene Expression in Liposarcoma
por: Liu, Tingting, et al.
Publicado: (2023)

Novel structural features in two ZHX homeodomains derived from a systematic study of single and multiple domains
por: Bird, Louise E, et al.
Publicado: (2010)

Tumor suppressor ZHX2 inhibits NAFLD–HCC progression via blocking LPL-mediated lipid uptake
por: Wu, Zhuanchang, et al.
Publicado: (2019)

Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation
por: Cao, Bo, et al.
Publicado: (2016)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
por: Xu, Yonggang, et al.
Publicado: (2021)

Impact of weight change during neoadjuvant chemotherapy on pathologic response in triple-negative breast cancer
por: Bao, Jean, et al.
Publicado: (2015)

Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients
por: You, Yanjie, et al.
Publicado: (2019)

Novel VHL substrate targets SFMBT1 and ZHX2 may be important prognostic predictors in patients with ccRCC
por: Chen, Yufeng, et al.
Publicado: (2021)

The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma
por: Wang, Lu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sag5vst1kr07r2qff5c56deecq